Setting the Standard Since 1971
Cart 0

Injectable Drug Compatibility News

Winter 2025

In this update we added a new monograph for AZTREONAM AND AVIBACTAM. We included new stability information to the monograph for AZTREONAM AND AVIBACTAM. Compatibility information was added for these drugs: ACETAMINOPHEN, AMIODARONE HYDROCHLORIDE, BUMETANIDE, CEFAZOLIN SODIUM, CEFOTAXIME SODIUM, CLONIDINE HYDROCHLORIDE, FUROSEMIDE, HEPARIN SODIUM, HYALURONIDASE, HYDROCORTISONE SODIUM SUCCINATE, IBUPROFEN, INSULIN, REGULAR, ISOSORBIDE DINITRATE, LEVETIRACETAM, LEVOFLOXACIN, MAGNESIUM SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, PANTOPRAZOLE SODIUM, PHLOROGLUCINOL, PHYTONADIONE, POTASSIUM CHLORIDE, PYRIDOXINE HYDROCHLORIDE, REMIFENTANIL, THIAMINE HYDROCHLORIDE, TOTAL PARENTERAL NUTRITION SOLUTIONS, and VANCOMYCIN HYDROCHLORIDE.

Read more →


Fall 2025

New and updated IV drug compatibility and stability information added to King Guide to Parenteral Admixtures.

Read more →


Summer 2025

New & updated IV drug compatibility and stability information added to King Guide to Parenteral Admixtures.

Read more →


Spring 2025

New and updated IV drug compatibility and stability information added to King Guide to Parenteral Admixtures.

Read more →


Winter 2024

New IV drug compatibility and stability data added to King Guide in our Winter 2024 update.

Read more →